chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Left ventricular dysfunction, Legionella test, Lung opacity, Mean cell volume increased, Nausea
Clinical narrative: 53 yo woman with no PMH was diagnosed with COVID-19 by PCR on 5/7/21. She had a mild illness with cough and fevers but did not require hospitalization. Her symptoms lasted about 1 week. She got her first dose of Pfizer COVID vaccine on 5/29 around 11 am. Within 4 hours (around 3 pm) she started to develop extreme fatigue, which she attributed to vaccine. This was followed by nausea, vomiting and diarrhea later that same day. The symptoms got worse on 5/30. Her diarrhea/GI symptoms resolved on 5/31. That day, she had a fever to 101.3. She continued to have fatigue, and started to have dyspnea, and presented to hospital on 6/1/21. On arrival to ED her vitals were 88/41, 36.1, 125, 18, 95% on RA (13:22). She become more hypotensive with nadir BP 63/48, HR 109 at 17:30, at which time she was started on norepinephrine. Physical exam at admission was notable for clear lungs, tenderness to palpation in the midepigastric and LUQ areas, and the absence of rash. Admission labs: WBC 31.3, Hb 14.2, Hct 43.0, Plt 144, MCV 96, 85% neutrophils, BNP 3117, Na 132, K 3.8, CO2 19, Cl 95, BUN 35, Create 4.62, gluc 133, protein 6.1, alb 2.2, TB 5.5, DB 2.9, Alk phos 159, ALT 47, AST 33, lactate 4.2, troponin I 0.047, random cortisol 93. Strep pneumo and legionella antigens negative. Hepatitis serologies, HIV test, all negative. COVID test by PCR was positive on 6/1/21. She was admitted to the ICU. The day following admission (6/2) CRP 32.4, ESR 106, LDH 399, ferritin 1626, procalcitonin 54.85. CT A/P unremarkable except for bilateral patchy airspace opacities. RUQ US unremarkable, including Dopplers. Echocardiogram (TTE) with LV systolic function mod-severely globally reduced, EF 35%, no valvular disease. Dopplers of LE showed small non-occlusive thrombus in R common femoral. The patient was seen by Infectious Diseases on HD#2 (6/2/21) and IVIG was recommended and administered due to suspicion for MIS-A. She had also been started on cefepime, vancomycin and metronidazole on admission. Blood, urine and resp cultures were negative. She continued to have high norepinephrine requirements, reaching 0.34 mcg/kg/min on 6/3. Due to ongoing shock (cardiogenic vs septic), a Swan-Ganz was placed on 6/4/21. RAP 11 mmHg, RV 38/10 mmHg, PA 40/20 (27) mmHg, PCWP 19 mm Hg, CO 5.75, CI 2.8, SVR 1100, MvO2: 70%. These were consistent with distributive/septic shock rather than cardiogenic.  The patient was able to be weaned from pressors on 6/5/21 at 11:55. Throughout her entire hospital stay, she was comfortable with no respiratory distress, and no abnormalities in mentation. She was transferred to the general medical floor and completed 7 days of antibiotics for empiric sepsis treatment. Labs at discharge on 6/8 showed procalcitonin 5.43, CRP 8.8, LDH 362, Ferritin 1511, TP 5.9, ALT 17, AST 29, Alk phs 158, TB 1.3, Alb 1.6, Create 0.98, WBC 32.5, Hb 7.8, Hct 22.9, Plt 100, neutrophils 70%. She was feeling well without complaints, and will follow up as an outpatient. She was prescribed Xarelto for DVT.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Neutrophil percentage increased, Platelet count decreased, Procalcitonin, Protein total decreased, Pyrexia
Clinical narrative: 53 yo woman with no PMH was diagnosed with COVID-19 by PCR on 5/7/21. She had a mild illness with cough and fevers but did not require hospitalization. Her symptoms lasted about 1 week. She got her first dose of Pfizer COVID vaccine on 5/29 around 11 am. Within 4 hours (around 3 pm) she started to develop extreme fatigue, which she attributed to vaccine. This was followed by nausea, vomiting and diarrhea later that same day. The symptoms got worse on 5/30. Her diarrhea/GI symptoms resolved on 5/31. That day, she had a fever to 101.3. She continued to have fatigue, and started to have dyspnea, and presented to hospital on 6/1/21. On arrival to ED her vitals were 88/41, 36.1, 125, 18, 95% on RA (13:22). She become more hypotensive with nadir BP 63/48, HR 109 at 17:30, at which time she was started on norepinephrine. Physical exam at admission was notable for clear lungs, tenderness to palpation in the midepigastric and LUQ areas, and the absence of rash. Admission labs: WBC 31.3, Hb 14.2, Hct 43.0, Plt 144, MCV 96, 85% neutrophils, BNP 3117, Na 132, K 3.8, CO2 19, Cl 95, BUN 35, Create 4.62, gluc 133, protein 6.1, alb 2.2, TB 5.5, DB 2.9, Alk phos 159, ALT 47, AST 33, lactate 4.2, troponin I 0.047, random cortisol 93. Strep pneumo and legionella antigens negative. Hepatitis serologies, HIV test, all negative. COVID test by PCR was positive on 6/1/21. She was admitted to the ICU. The day following admission (6/2) CRP 32.4, ESR 106, LDH 399, ferritin 1626, procalcitonin 54.85. CT A/P unremarkable except for bilateral patchy airspace opacities. RUQ US unremarkable, including Dopplers. Echocardiogram (TTE) with LV systolic function mod-severely globally reduced, EF 35%, no valvular disease. Dopplers of LE showed small non-occlusive thrombus in R common femoral. The patient was seen by Infectious Diseases on HD#2 (6/2/21) and IVIG was recommended and administered due to suspicion for MIS-A. She had also been started on cefepime, vancomycin and metronidazole on admission. Blood, urine and resp cultures were negative. She continued to have high norepinephrine requirements, reaching 0.34 mcg/kg/min on 6/3. Due to ongoing shock (cardiogenic vs septic), a Swan-Ganz was placed on 6/4/21. RAP 11 mmHg, RV 38/10 mmHg, PA 40/20 (27) mmHg, PCWP 19 mm Hg, CO 5.75, CI 2.8, SVR 1100, MvO2: 70%. These were consistent with distributive/septic shock rather than cardiogenic.  The patient was able to be weaned from pressors on 6/5/21 at 11:55. Throughout her entire hospital stay, she was comfortable with no respiratory distress, and no abnormalities in mentation. She was transferred to the general medical floor and completed 7 days of antibiotics for empiric sepsis treatment. Labs at discharge on 6/8 showed procalcitonin 5.43, CRP 8.8, LDH 362, Ferritin 1511, TP 5.9, ALT 17, AST 29, Alk phs 158, TB 1.3, Alb 1.6, Create 0.98, WBC 32.5, Hb 7.8, Hct 22.9, Plt 100, neutrophils 70%. She was feeling well without complaints, and will follow up as an outpatient. She was prescribed Xarelto for DVT.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Streptococcus test negative, Swan ganz catheter placement, Thrombosis, Troponin I increased, Tuberculosis
Clinical narrative: 53 yo woman with no PMH was diagnosed with COVID-19 by PCR on 5/7/21. She had a mild illness with cough and fevers but did not require hospitalization. Her symptoms lasted about 1 week. She got her first dose of Pfizer COVID vaccine on 5/29 around 11 am. Within 4 hours (around 3 pm) she started to develop extreme fatigue, which she attributed to vaccine. This was followed by nausea, vomiting and diarrhea later that same day. The symptoms got worse on 5/30. Her diarrhea/GI symptoms resolved on 5/31. That day, she had a fever to 101.3. She continued to have fatigue, and started to have dyspnea, and presented to hospital on 6/1/21. On arrival to ED her vitals were 88/41, 36.1, 125, 18, 95% on RA (13:22). She become more hypotensive with nadir BP 63/48, HR 109 at 17:30, at which time she was started on norepinephrine. Physical exam at admission was notable for clear lungs, tenderness to palpation in the midepigastric and LUQ areas, and the absence of rash. Admission labs: WBC 31.3, Hb 14.2, Hct 43.0, Plt 144, MCV 96, 85% neutrophils, BNP 3117, Na 132, K 3.8, CO2 19, Cl 95, BUN 35, Create 4.62, gluc 133, protein 6.1, alb 2.2, TB 5.5, DB 2.9, Alk phos 159, ALT 47, AST 33, lactate 4.2, troponin I 0.047, random cortisol 93. Strep pneumo and legionella antigens negative. Hepatitis serologies, HIV test, all negative. COVID test by PCR was positive on 6/1/21. She was admitted to the ICU. The day following admission (6/2) CRP 32.4, ESR 106, LDH 399, ferritin 1626, procalcitonin 54.85. CT A/P unremarkable except for bilateral patchy airspace opacities. RUQ US unremarkable, including Dopplers. Echocardiogram (TTE) with LV systolic function mod-severely globally reduced, EF 35%, no valvular disease. Dopplers of LE showed small non-occlusive thrombus in R common femoral. The patient was seen by Infectious Diseases on HD#2 (6/2/21) and IVIG was recommended and administered due to suspicion for MIS-A. She had also been started on cefepime, vancomycin and metronidazole on admission. Blood, urine and resp cultures were negative. She continued to have high norepinephrine requirements, reaching 0.34 mcg/kg/min on 6/3. Due to ongoing shock (cardiogenic vs septic), a Swan-Ganz was placed on 6/4/21. RAP 11 mmHg, RV 38/10 mmHg, PA 40/20 (27) mmHg, PCWP 19 mm Hg, CO 5.75, CI 2.8, SVR 1100, MvO2: 70%. These were consistent with distributive/septic shock rather than cardiogenic.  The patient was able to be weaned from pressors on 6/5/21 at 11:55. Throughout her entire hospital stay, she was comfortable with no respiratory distress, and no abnormalities in mentation. She was transferred to the general medical floor and completed 7 days of antibiotics for empiric sepsis treatment. Labs at discharge on 6/8 showed procalcitonin 5.43, CRP 8.8, LDH 362, Ferritin 1511, TP 5.9, ALT 17, AST 29, Alk phs 158, TB 1.3, Alb 1.6, Create 0.98, WBC 32.5, Hb 7.8, Hct 22.9, Plt 100, neutrophils 70%. She was feeling well without complaints, and will follow up as an outpatient. She was prescribed Xarelto for DVT.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound Doppler abnormal, Ultrasound abdomen normal, Vomiting, White blood cell count increased
Clinical narrative: 53 yo woman with no PMH was diagnosed with COVID-19 by PCR on 5/7/21. She had a mild illness with cough and fevers but did not require hospitalization. Her symptoms lasted about 1 week. She got her first dose of Pfizer COVID vaccine on 5/29 around 11 am. Within 4 hours (around 3 pm) she started to develop extreme fatigue, which she attributed to vaccine. This was followed by nausea, vomiting and diarrhea later that same day. The symptoms got worse on 5/30. Her diarrhea/GI symptoms resolved on 5/31. That day, she had a fever to 101.3. She continued to have fatigue, and started to have dyspnea, and presented to hospital on 6/1/21. On arrival to ED her vitals were 88/41, 36.1, 125, 18, 95% on RA (13:22). She become more hypotensive with nadir BP 63/48, HR 109 at 17:30, at which time she was started on norepinephrine. Physical exam at admission was notable for clear lungs, tenderness to palpation in the midepigastric and LUQ areas, and the absence of rash. Admission labs: WBC 31.3, Hb 14.2, Hct 43.0, Plt 144, MCV 96, 85% neutrophils, BNP 3117, Na 132, K 3.8, CO2 19, Cl 95, BUN 35, Create 4.62, gluc 133, protein 6.1, alb 2.2, TB 5.5, DB 2.9, Alk phos 159, ALT 47, AST 33, lactate 4.2, troponin I 0.047, random cortisol 93. Strep pneumo and legionella antigens negative. Hepatitis serologies, HIV test, all negative. COVID test by PCR was positive on 6/1/21. She was admitted to the ICU. The day following admission (6/2) CRP 32.4, ESR 106, LDH 399, ferritin 1626, procalcitonin 54.85. CT A/P unremarkable except for bilateral patchy airspace opacities. RUQ US unremarkable, including Dopplers. Echocardiogram (TTE) with LV systolic function mod-severely globally reduced, EF 35%, no valvular disease. Dopplers of LE showed small non-occlusive thrombus in R common femoral. The patient was seen by Infectious Diseases on HD#2 (6/2/21) and IVIG was recommended and administered due to suspicion for MIS-A. She had also been started on cefepime, vancomycin and metronidazole on admission. Blood, urine and resp cultures were negative. She continued to have high norepinephrine requirements, reaching 0.34 mcg/kg/min on 6/3. Due to ongoing shock (cardiogenic vs septic), a Swan-Ganz was placed on 6/4/21. RAP 11 mmHg, RV 38/10 mmHg, PA 40/20 (27) mmHg, PCWP 19 mm Hg, CO 5.75, CI 2.8, SVR 1100, MvO2: 70%. These were consistent with distributive/septic shock rather than cardiogenic.  The patient was able to be weaned from pressors on 6/5/21 at 11:55. Throughout her entire hospital stay, she was comfortable with no respiratory distress, and no abnormalities in mentation. She was transferred to the general medical floor and completed 7 days of antibiotics for empiric sepsis treatment. Labs at discharge on 6/8 showed procalcitonin 5.43, CRP 8.8, LDH 362, Ferritin 1511, TP 5.9, ALT 17, AST 29, Alk phs 158, TB 1.3, Alb 1.6, Create 0.98, WBC 32.5, Hb 7.8, Hct 22.9, Plt 100, neutrophils 70%. She was feeling well without complaints, and will follow up as an outpatient. She was prescribed Xarelto for DVT.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac monitoring, Colonoscopy, Electrocardiogram
Clinical narrative: Second shot in series received 3/19/21.   When undergoing routine colonoscopy on 4/28/21, I was found to be in atrial fibrillation.  This was not present in prior EKGs or in my primary care checkup in January 2021.  Following up with cardiologist, taking Eliquis, submitted 2 weeks of cardiac monitoring  and will undergo cardioversion if indicated.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Urticaria
Clinical narrative: Developed itching rash on neck and back
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Patient was dizzy and nauseous for about 15 minutes
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash in groin area, legs, chest and neck
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Chest pain, Echocardiogram abnormal, Electrocardiogram abnormal, Heart rate abnormal
Clinical narrative: I had my first Pfizer vaccine on March 27th.  Around April 9th I began to feel chest pain.  I went to the ER on April 13th and they initially thought I was having a heart attack.  Ultimately I was in the ICU overnight with pericarditis, which effected my heart rate.  I had several EKGs, blood tests and an Echocardiogram.  I was sent home with meds for three weeks.  I had my second doze of Pfizer vaccine on April 24th.  I was back in the ER on May 24th, sent home yet back again on May 31st after a week of heart rate issues.  I started in the ICU, stayed overnight in the hospital and then send home with meds for four weeks.  The diagnosis was a return of the pericarditis.  I?m now in recovery mode.  My concern is basically a healthy sixty-six year old male with no heart issues ended up in the ICU with pericarditis just over two weeks after the Pfizer vaccine and then back again the next month after I had received the recommendation to go live life with no needs of a follow-up appointment needed from the cardiologist.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Pericarditis
Clinical narrative: I had my first Pfizer vaccine on March 27th.  Around April 9th I began to feel chest pain.  I went to the ER on April 13th and they initially thought I was having a heart attack.  Ultimately I was in the ICU overnight with pericarditis, which effected my heart rate.  I had several EKGs, blood tests and an Echocardiogram.  I was sent home with meds for three weeks.  I had my second doze of Pfizer vaccine on April 24th.  I was back in the ER on May 24th, sent home yet back again on May 31st after a week of heart rate issues.  I started in the ICU, stayed overnight in the hospital and then send home with meds for four weeks.  The diagnosis was a return of the pericarditis.  I?m now in recovery mode.  My concern is basically a healthy sixty-six year old male with no heart issues ended up in the ICU with pericarditis just over two weeks after the Pfizer vaccine and then back again the next month after I had received the recommendation to go live life with no needs of a follow-up appointment needed from the cardiologist.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: minor vertigo--lasted about 18 hours. Reported to primary care physician the following morning (spoke to PA, did not visit the office). It was gone by afternoon. No treatment.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Peripheral swelling, Rash
Clinical narrative: Arm Swelling, Red and hot from shoulder to elbow. Rash on left arm, lower back, and right thigh.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Full blood count, Headache, Liver function test, Metabolic function test
Clinical narrative: Headache, fever, diarrhea, nausea/vomiting o/g x3 months
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, SARS-CoV-2 test, Vomiting
Clinical narrative: Headache, fever, diarrhea, nausea/vomiting o/g x3 months
Age: 67.0
Sex: F
Vaccine: UNK
Symptoms: Injection site pain, Musculoskeletal stiffness, Neck pain, Pain of skin
Clinical narrative: Pain in needle strike area for 3 months. Very concerned. On  yesterday my neck was stiff and painful, the pain  spread down to the vaccine stick Decided to contact CDC.  Using  hot pad and a cold pad.  Tylenol Extra Strength, it does not get to the stick area. The pain feels like it?s in my flesh, not ny bones. A feeling I?ve never felt before.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Abdominal pain upper, Alanine aminotransferase normal, Albumin globulin ratio normal, Aspartate aminotransferase normal
Clinical narrative: er HPI: 26 y.o. female who presents with chest pain which began about an hour PTA. She was watching TV, took a sip of Tea. She describes the pain as pressure, located to the epigastric and and left upper quadrant of the abdomen with no radiation. Pain worse on lying down. Denies nausea, light headedness or diaphoresis. Result Value Ref Range   Lipase 120 73 - 393 U/L MAGNESIUM   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Magnesium 2.1 1.8 - 2.4 MG/DL CK (CPK) CREATINE PHOSPHOKINASE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase Total 153 26 - 192 U/L CKMB   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase-MB 0.7 0.0 - 3.6 NG/ML TROPONIN   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL D-DIMER,QUANTITATIVE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   D-Dimer 603 (HH) 0 - 400 NG/ML FEU TROPONIN   Collection Time: 06/11/21  9:00 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL        Old charts were reviewed per EMR.  Pertinent details are summarized above. All laboratory, radiologic, and EKG studies that were performed in the Emergency Department were a necessary part of the evaluation needed to exclude unstable or  emergent medical conditions.    ED Course as of Jun 11 2128 Fri Jun 11, 2021 2125 Patint remains chest pain free while in ED.  D-Dimer(!!): 603   ED Course User Index MD Patient remains chest pain free and hemodinamically stable while in ED.   Patient was hemodynamically and neurologically stable in the ED.  Pertinent studies were reviewed as above.    The patient received: Medications aspirin chewable tablet 324 mg (324 mg Oral Patient Refused 6/11/21 1915) pantoprazole (PROTONIX) injection 40 mg (40 mg Intravenous Given 6/11/21 2007)
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Basophil count decreased, Basophil percentage decreased, Blood albumin normal, Blood alkaline phosphatase normal, Blood bilirubin decreased
Clinical narrative: er HPI: 26 y.o. female who presents with chest pain which began about an hour PTA. She was watching TV, took a sip of Tea. She describes the pain as pressure, located to the epigastric and and left upper quadrant of the abdomen with no radiation. Pain worse on lying down. Denies nausea, light headedness or diaphoresis. Result Value Ref Range   Lipase 120 73 - 393 U/L MAGNESIUM   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Magnesium 2.1 1.8 - 2.4 MG/DL CK (CPK) CREATINE PHOSPHOKINASE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase Total 153 26 - 192 U/L CKMB   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase-MB 0.7 0.0 - 3.6 NG/ML TROPONIN   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL D-DIMER,QUANTITATIVE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   D-Dimer 603 (HH) 0 - 400 NG/ML FEU TROPONIN   Collection Time: 06/11/21  9:00 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL        Old charts were reviewed per EMR.  Pertinent details are summarized above. All laboratory, radiologic, and EKG studies that were performed in the Emergency Department were a necessary part of the evaluation needed to exclude unstable or  emergent medical conditions.    ED Course as of Jun 11 2128 Fri Jun 11, 2021 2125 Patint remains chest pain free while in ED.  D-Dimer(!!): 603   ED Course User Index MD Patient remains chest pain free and hemodinamically stable while in ED.   Patient was hemodynamically and neurologically stable in the ED.  Pertinent studies were reviewed as above.    The patient received: Medications aspirin chewable tablet 324 mg (324 mg Oral Patient Refused 6/11/21 1915) pantoprazole (PROTONIX) injection 40 mg (40 mg Intravenous Given 6/11/21 2007)
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Blood calcium normal, Blood chloride normal, Blood creatinine increased, Blood glucose normal, Blood potassium normal
Clinical narrative: er HPI: 26 y.o. female who presents with chest pain which began about an hour PTA. She was watching TV, took a sip of Tea. She describes the pain as pressure, located to the epigastric and and left upper quadrant of the abdomen with no radiation. Pain worse on lying down. Denies nausea, light headedness or diaphoresis. Result Value Ref Range   Lipase 120 73 - 393 U/L MAGNESIUM   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Magnesium 2.1 1.8 - 2.4 MG/DL CK (CPK) CREATINE PHOSPHOKINASE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase Total 153 26 - 192 U/L CKMB   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase-MB 0.7 0.0 - 3.6 NG/ML TROPONIN   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL D-DIMER,QUANTITATIVE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   D-Dimer 603 (HH) 0 - 400 NG/ML FEU TROPONIN   Collection Time: 06/11/21  9:00 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL        Old charts were reviewed per EMR.  Pertinent details are summarized above. All laboratory, radiologic, and EKG studies that were performed in the Emergency Department were a necessary part of the evaluation needed to exclude unstable or  emergent medical conditions.    ED Course as of Jun 11 2128 Fri Jun 11, 2021 2125 Patint remains chest pain free while in ED.  D-Dimer(!!): 603   ED Course User Index MD Patient remains chest pain free and hemodinamically stable while in ED.   Patient was hemodynamically and neurologically stable in the ED.  Pertinent studies were reviewed as above.    The patient received: Medications aspirin chewable tablet 324 mg (324 mg Oral Patient Refused 6/11/21 1915) pantoprazole (PROTONIX) injection 40 mg (40 mg Intravenous Given 6/11/21 2007)
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Blood sodium normal, Blood urea normal, Carbon dioxide normal, Chest pain, Eosinophil count decreased
Clinical narrative: er HPI: 26 y.o. female who presents with chest pain which began about an hour PTA. She was watching TV, took a sip of Tea. She describes the pain as pressure, located to the epigastric and and left upper quadrant of the abdomen with no radiation. Pain worse on lying down. Denies nausea, light headedness or diaphoresis. Result Value Ref Range   Lipase 120 73 - 393 U/L MAGNESIUM   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Magnesium 2.1 1.8 - 2.4 MG/DL CK (CPK) CREATINE PHOSPHOKINASE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase Total 153 26 - 192 U/L CKMB   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase-MB 0.7 0.0 - 3.6 NG/ML TROPONIN   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL D-DIMER,QUANTITATIVE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   D-Dimer 603 (HH) 0 - 400 NG/ML FEU TROPONIN   Collection Time: 06/11/21  9:00 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL        Old charts were reviewed per EMR.  Pertinent details are summarized above. All laboratory, radiologic, and EKG studies that were performed in the Emergency Department were a necessary part of the evaluation needed to exclude unstable or  emergent medical conditions.    ED Course as of Jun 11 2128 Fri Jun 11, 2021 2125 Patint remains chest pain free while in ED.  D-Dimer(!!): 603   ED Course User Index MD Patient remains chest pain free and hemodinamically stable while in ED.   Patient was hemodynamically and neurologically stable in the ED.  Pertinent studies were reviewed as above.    The patient received: Medications aspirin chewable tablet 324 mg (324 mg Oral Patient Refused 6/11/21 1915) pantoprazole (PROTONIX) injection 40 mg (40 mg Intravenous Given 6/11/21 2007)
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Eosinophil percentage, Glomerular filtration rate decreased, Haematocrit normal, Haemoglobin normal, Immature granulocyte count
Clinical narrative: er HPI: 26 y.o. female who presents with chest pain which began about an hour PTA. She was watching TV, took a sip of Tea. She describes the pain as pressure, located to the epigastric and and left upper quadrant of the abdomen with no radiation. Pain worse on lying down. Denies nausea, light headedness or diaphoresis. Result Value Ref Range   Lipase 120 73 - 393 U/L MAGNESIUM   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Magnesium 2.1 1.8 - 2.4 MG/DL CK (CPK) CREATINE PHOSPHOKINASE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase Total 153 26 - 192 U/L CKMB   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase-MB 0.7 0.0 - 3.6 NG/ML TROPONIN   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL D-DIMER,QUANTITATIVE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   D-Dimer 603 (HH) 0 - 400 NG/ML FEU TROPONIN   Collection Time: 06/11/21  9:00 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL        Old charts were reviewed per EMR.  Pertinent details are summarized above. All laboratory, radiologic, and EKG studies that were performed in the Emergency Department were a necessary part of the evaluation needed to exclude unstable or  emergent medical conditions.    ED Course as of Jun 11 2128 Fri Jun 11, 2021 2125 Patint remains chest pain free while in ED.  D-Dimer(!!): 603   ED Course User Index MD Patient remains chest pain free and hemodinamically stable while in ED.   Patient was hemodynamically and neurologically stable in the ED.  Pertinent studies were reviewed as above.    The patient received: Medications aspirin chewable tablet 324 mg (324 mg Oral Patient Refused 6/11/21 1915) pantoprazole (PROTONIX) injection 40 mg (40 mg Intravenous Given 6/11/21 2007)
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Lipase, Lymphocyte count, Lymphocyte percentage, Mean cell haemoglobin, Mean cell haemoglobin concentration normal
Clinical narrative: er HPI: 26 y.o. female who presents with chest pain which began about an hour PTA. She was watching TV, took a sip of Tea. She describes the pain as pressure, located to the epigastric and and left upper quadrant of the abdomen with no radiation. Pain worse on lying down. Denies nausea, light headedness or diaphoresis. Result Value Ref Range   Lipase 120 73 - 393 U/L MAGNESIUM   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Magnesium 2.1 1.8 - 2.4 MG/DL CK (CPK) CREATINE PHOSPHOKINASE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase Total 153 26 - 192 U/L CKMB   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase-MB 0.7 0.0 - 3.6 NG/ML TROPONIN   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL D-DIMER,QUANTITATIVE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   D-Dimer 603 (HH) 0 - 400 NG/ML FEU TROPONIN   Collection Time: 06/11/21  9:00 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL        Old charts were reviewed per EMR.  Pertinent details are summarized above. All laboratory, radiologic, and EKG studies that were performed in the Emergency Department were a necessary part of the evaluation needed to exclude unstable or  emergent medical conditions.    ED Course as of Jun 11 2128 Fri Jun 11, 2021 2125 Patint remains chest pain free while in ED.  D-Dimer(!!): 603   ED Course User Index MD Patient remains chest pain free and hemodinamically stable while in ED.   Patient was hemodynamically and neurologically stable in the ED.  Pertinent studies were reviewed as above.    The patient received: Medications aspirin chewable tablet 324 mg (324 mg Oral Patient Refused 6/11/21 1915) pantoprazole (PROTONIX) injection 40 mg (40 mg Intravenous Given 6/11/21 2007)
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Mean cell volume decreased, Mean platelet volume normal, Metabolic function test, Monocyte count decreased, Monocyte percentage
Clinical narrative: er HPI: 26 y.o. female who presents with chest pain which began about an hour PTA. She was watching TV, took a sip of Tea. She describes the pain as pressure, located to the epigastric and and left upper quadrant of the abdomen with no radiation. Pain worse on lying down. Denies nausea, light headedness or diaphoresis. Result Value Ref Range   Lipase 120 73 - 393 U/L MAGNESIUM   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Magnesium 2.1 1.8 - 2.4 MG/DL CK (CPK) CREATINE PHOSPHOKINASE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase Total 153 26 - 192 U/L CKMB   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase-MB 0.7 0.0 - 3.6 NG/ML TROPONIN   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL D-DIMER,QUANTITATIVE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   D-Dimer 603 (HH) 0 - 400 NG/ML FEU TROPONIN   Collection Time: 06/11/21  9:00 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL        Old charts were reviewed per EMR.  Pertinent details are summarized above. All laboratory, radiologic, and EKG studies that were performed in the Emergency Department were a necessary part of the evaluation needed to exclude unstable or  emergent medical conditions.    ED Course as of Jun 11 2128 Fri Jun 11, 2021 2125 Patint remains chest pain free while in ED.  D-Dimer(!!): 603   ED Course User Index MD Patient remains chest pain free and hemodinamically stable while in ED.   Patient was hemodynamically and neurologically stable in the ED.  Pertinent studies were reviewed as above.    The patient received: Medications aspirin chewable tablet 324 mg (324 mg Oral Patient Refused 6/11/21 1915) pantoprazole (PROTONIX) injection 40 mg (40 mg Intravenous Given 6/11/21 2007)
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Neutrophil count, Neutrophil percentage, Platelet count normal, Protein total normal, Red blood cell count normal
Clinical narrative: er HPI: 26 y.o. female who presents with chest pain which began about an hour PTA. She was watching TV, took a sip of Tea. She describes the pain as pressure, located to the epigastric and and left upper quadrant of the abdomen with no radiation. Pain worse on lying down. Denies nausea, light headedness or diaphoresis. Result Value Ref Range   Lipase 120 73 - 393 U/L MAGNESIUM   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Magnesium 2.1 1.8 - 2.4 MG/DL CK (CPK) CREATINE PHOSPHOKINASE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase Total 153 26 - 192 U/L CKMB   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase-MB 0.7 0.0 - 3.6 NG/ML TROPONIN   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL D-DIMER,QUANTITATIVE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   D-Dimer 603 (HH) 0 - 400 NG/ML FEU TROPONIN   Collection Time: 06/11/21  9:00 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL        Old charts were reviewed per EMR.  Pertinent details are summarized above. All laboratory, radiologic, and EKG studies that were performed in the Emergency Department were a necessary part of the evaluation needed to exclude unstable or  emergent medical conditions.    ED Course as of Jun 11 2128 Fri Jun 11, 2021 2125 Patint remains chest pain free while in ED.  D-Dimer(!!): 603   ED Course User Index MD Patient remains chest pain free and hemodinamically stable while in ED.   Patient was hemodynamically and neurologically stable in the ED.  Pertinent studies were reviewed as above.    The patient received: Medications aspirin chewable tablet 324 mg (324 mg Oral Patient Refused 6/11/21 1915) pantoprazole (PROTONIX) injection 40 mg (40 mg Intravenous Given 6/11/21 2007)
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Red cell distribution width normal, White blood cell count increased
Clinical narrative: er HPI: 26 y.o. female who presents with chest pain which began about an hour PTA. She was watching TV, took a sip of Tea. She describes the pain as pressure, located to the epigastric and and left upper quadrant of the abdomen with no radiation. Pain worse on lying down. Denies nausea, light headedness or diaphoresis. Result Value Ref Range   Lipase 120 73 - 393 U/L MAGNESIUM   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Magnesium 2.1 1.8 - 2.4 MG/DL CK (CPK) CREATINE PHOSPHOKINASE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase Total 153 26 - 192 U/L CKMB   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Creatine Kinase-MB 0.7 0.0 - 3.6 NG/ML TROPONIN   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL D-DIMER,QUANTITATIVE   Collection Time: 06/11/21  7:24 PM Result Value Ref Range   D-Dimer 603 (HH) 0 - 400 NG/ML FEU TROPONIN   Collection Time: 06/11/21  9:00 PM Result Value Ref Range   Troponin I 0.00 0.00 - 0.06 ng/mL        Old charts were reviewed per EMR.  Pertinent details are summarized above. All laboratory, radiologic, and EKG studies that were performed in the Emergency Department were a necessary part of the evaluation needed to exclude unstable or  emergent medical conditions.    ED Course as of Jun 11 2128 Fri Jun 11, 2021 2125 Patint remains chest pain free while in ED.  D-Dimer(!!): 603   ED Course User Index MD Patient remains chest pain free and hemodinamically stable while in ED.   Patient was hemodynamically and neurologically stable in the ED.  Pertinent studies were reviewed as above.    The patient received: Medications aspirin chewable tablet 324 mg (324 mg Oral Patient Refused 6/11/21 1915) pantoprazole (PROTONIX) injection 40 mg (40 mg Intravenous Given 6/11/21 2007)
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthma, Chills, Eye pruritus, Lymphadenopathy, Pain in extremity
Clinical narrative: 11 Hours after injection had 102 degree fever and chills, Slightly sore arm, swollen lymph nodes in left armpit and left side of neck for 3 days. Swollen lymph nodes near left collar bone for 5 weeks. It was the size of a large pea. Developed an asthmatic cough and allergies heightened with nasal drip and itchy eyes.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Upper-airway cough syndrome
Clinical narrative: 11 Hours after injection had 102 degree fever and chills, Slightly sore arm, swollen lymph nodes in left armpit and left side of neck for 3 days. Swollen lymph nodes near left collar bone for 5 weeks. It was the size of a large pea. Developed an asthmatic cough and allergies heightened with nasal drip and itchy eyes.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Feeling abnormal, Haemoptysis, Pain
Clinical narrative: As per patient an hour later after she got the shot, she started feeling really tired and went to bed. She was not able to get up till 12pm to 1pm next afternoon.  When she woke up she felt chalky feeling in her mouth and spat up blood couple of times. When patient called pharmacy was advised to call PCP. On the follow up call patient informed that doctor advised her to go in if she had those symptoms again. As per patient she didn't have those symptoms again so didn't need to go in. Apart from this, patient had more expected side-effects such as backache, local site pain, and tiredness. On the follow up call patient mentioned that she's feeling lot better and doesn't have any side-effects at the moment.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bundle branch block right, Chest pain, Echocardiogram normal, Electrocardiogram ST segment elevation, Electrocardiogram repolarisation abnormality
Clinical narrative: Acute Myocarditis with chest pain and elevated troponin (peak level 27) occurring 3 days after 2nd Pfizer covid shot. Treatment with Ketorolac and morphine, clinically improving at the time of report.  Echo reassuring with good function and no effusion, ECG initially with RBBB repeat ECG with early depolarization, no arrhythmias
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myocarditis, Troponin increased
Clinical narrative: Acute Myocarditis with chest pain and elevated troponin (peak level 27) occurring 3 days after 2nd Pfizer covid shot. Treatment with Ketorolac and morphine, clinically improving at the time of report.  Echo reassuring with good function and no effusion, ECG initially with RBBB repeat ECG with early depolarization, no arrhythmias
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Laboratory test, Myocarditis
Clinical narrative: Acute Myocarditis with chest pain and elevated troponin (peak level 27) occurring 3 days after 2nd Pfizer covid shot. Treatment with Ketorolac and morphine, clinically improving at the time of report.  Echo reassuring with good function and no effusion, ECG initially with RBBB repeat ECG with early depolarization, no arrhythmias
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray normal, Chest pain, Electrocardiogram, Malaise, Myocarditis
Clinical narrative: Acute Myocarditis with chest pain and elevated troponin (peak level 27) occurring 3 days after 2nd Pfizer covid shot. Treatment with Ketorolac and morphine, clinically improving at the time of report.  Echo reassuring with good function and no effusion, ECG initially with RBBB repeat ECG with early depolarization, no arrhythmias
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Troponin
Clinical narrative: Acute Myocarditis with chest pain and elevated troponin (peak level 27) occurring 3 days after 2nd Pfizer covid shot. Treatment with Ketorolac and morphine, clinically improving at the time of report.  Echo reassuring with good function and no effusion, ECG initially with RBBB repeat ECG with early depolarization, no arrhythmias
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: PATIENT WAS OBSERVED FROM 0938 - 0953 WITH NO DISTRESS OR COMPLAINTS,   PATIENT CALLED AT 1100 COMPLAINING OF NUMBNESS IN HAND AND FINGERS
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dysphagia, Headache, Hypersomnia, Injection site pain
Clinical narrative: injection site pain, headache, daytime sleepiness, sleep excessive, sore throat, swallowing difficult (because of throat pain), difficulty talking because of pain, lethargy, nasal stuffiness, nasal drip, swollen cervical glands, cough lasted 5 days, left cheek swelling
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Lymphadenopathy, Nasal congestion, Oropharyngeal pain, Somnolence
Clinical narrative: injection site pain, headache, daytime sleepiness, sleep excessive, sore throat, swallowing difficult (because of throat pain), difficulty talking because of pain, lethargy, nasal stuffiness, nasal drip, swollen cervical glands, cough lasted 5 days, left cheek swelling
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Speech disorder, Swelling face, Upper-airway cough syndrome
Clinical narrative: injection site pain, headache, daytime sleepiness, sleep excessive, sore throat, swallowing difficult (because of throat pain), difficulty talking because of pain, lethargy, nasal stuffiness, nasal drip, swollen cervical glands, cough lasted 5 days, left cheek swelling
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Catheterisation cardiac abnormal, Condition aggravated, Coronary artery occlusion, Hypertension
Clinical narrative: Patient went to hospital with hypertensive crisis (said blood pressure was VERY high) on May 18, 2021. She said they did a heart catheterization, in which everything looked good except for the artery in the back of the heart was 70% blocked. She said she is now on a cholesterol medication, an additional blood pressure medication, they increased her current blood pressure medication, and also put her on a blood thinner.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertensive crisis
Clinical narrative: Patient went to hospital with hypertensive crisis (said blood pressure was VERY high) on May 18, 2021. She said they did a heart catheterization, in which everything looked good except for the artery in the back of the heart was 70% blocked. She said she is now on a cholesterol medication, an additional blood pressure medication, they increased her current blood pressure medication, and also put her on a blood thinner.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Injection site pain
Clinical narrative: Chills, profuse sweating, and pain at injection site
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Cold urticaria, Peripheral swelling, Skin test positive, Urticaria
Clinical narrative: Confirmed COLD URTICARIA: swelling of hands and feet, and hives.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Case was symptomatic, but not hospitalized.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Loss of consciousness, Syncope
Clinical narrative: Patient received vaccine and immediately after lost consciousness.  She did not display an allergic reaction and was checked by paramedics. She fainted with no other symptoms
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pinguecula
Clinical narrative: Pinguecula; steroid drops; relieved but not yet cured
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Paraesthesia, Vision blurred
Clinical narrative: About 2 min after my 2nd shot, I started feeling tingling in the left side of my neck, behind my ear, and spreading through my face (tingling and numbness). Then, about 10 min later, I experienced very blurry vision. It's been six weeks and my vision has not recovered. While it's not as blurry as it was immediately following the vaccine, I now have consistent blurry vision within about two feet - which has resulted in me having headaches by the end of the day. I did not need glasses or contacts prior to the vaccine and had no issue with my vision.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein, COVID-19, Chest X-ray normal, Fibrin D dimer, Insomnia
Clinical narrative: patient presented to emergency department 6/12/2021 after testing positive 6/7/2021 (approximately 6 months after completing Pfizer mRNA vaccine series). He describes feeling generally unwell, difficulty sleeping and difficulty moving left upper extremity. Neurology and infectious disease consulted; ruled out stroke/TIA and treated with dexamethasone even though not requiring supplemental oxygen.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, Mobility decreased, SARS-CoV-2 test positive
Clinical narrative: patient presented to emergency department 6/12/2021 after testing positive 6/7/2021 (approximately 6 months after completing Pfizer mRNA vaccine series). He describes feeling generally unwell, difficulty sleeping and difficulty moving left upper extremity. Neurology and infectious disease consulted; ruled out stroke/TIA and treated with dexamethasone even though not requiring supplemental oxygen.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: The patient is younger that the EUA approved age of 18.  Patient is 17 years old and should not have received the vaccine.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Abdominal pain upper, Endoscopic ultrasound
Clinical narrative: Pain in my upper right abdominal region, bloating.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Palpitations
Clinical narrative: After 2 months I started getting heart palpitations, shortness of breath and chest pain. This is months after vaccination. Vaccine was Moderna. Both doses taken.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Coma, Posterior reversible encephalopathy syndrome
Clinical narrative: PRES requiring hospitalization.  Coma: 4/18/2021 - 4/192021.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram, Fall, Hyperhidrosis, Malaise, Muscle twitching
Clinical narrative: This incident was reported to me by a Medical Professional on the scene. The patient got his vaccination while sitting down upon standing upright to move to the recovery area he fell backwards  . The time was <3minutes post vaccination. I was informed  that the patient did not sustain observable injury.  No visible signs of trauma as per report.  There was EMS on site as per our protocol  and  they communicated with 911 to receive the assistance needed. The EMS on site started the  assessment, evaluation and maintenance of safety while awaiting squad arrival. Pt was observed to exhibit seizure like activity.  Duration  = 45 seconds. Pt demonstrated posturing of the upper extremities, Nystagmus of the eyes, as well as convulsive / twitching movements during the described event. Patient denies preceding  ideas to event. Est 5 minutes post oriented, he became diaphoretic and verbalized feeling ill. They lowered him to the ground for safety.  A&Ox4 and was able to verbalize agreement to receive observation / treatment at  the emergency department.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Nystagmus, Seizure like phenomena
Clinical narrative: This incident was reported to me by a Medical Professional on the scene. The patient got his vaccination while sitting down upon standing upright to move to the recovery area he fell backwards  . The time was <3minutes post vaccination. I was informed  that the patient did not sustain observable injury.  No visible signs of trauma as per report.  There was EMS on site as per our protocol  and  they communicated with 911 to receive the assistance needed. The EMS on site started the  assessment, evaluation and maintenance of safety while awaiting squad arrival. Pt was observed to exhibit seizure like activity.  Duration  = 45 seconds. Pt demonstrated posturing of the upper extremities, Nystagmus of the eyes, as well as convulsive / twitching movements during the described event. Patient denies preceding  ideas to event. Est 5 minutes post oriented, he became diaphoretic and verbalized feeling ill. They lowered him to the ground for safety.  A&Ox4 and was able to verbalize agreement to receive observation / treatment at  the emergency department.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient received Pfizer for first vaccine injection and Moderna for 2nd vaccine injection
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Sudden hearing loss
Clinical narrative: Sudden lost of hearing in right ear.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling, Tenderness
Clinical narrative: I have an area around my collar bone on my left side close to the neck that is swollen and is tender to the touch and is about 3 inches long.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac dysfunction, Chest pain, Decreased appetite, Dehydration, Feeling cold
Clinical narrative: The next day ended up being sick with sweating,  dehydration,  cold, no appetite and slept all day,  The 2nd day felt a little better and started to have chest pains at night. 3rd day in Morning,  went to emergency room and they first described me as having a heart attack.  Was in hospital for (4) days and result is having takotsubo cardiomyopathy. Said my heart was only operating at 50%